The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.07
Bid: 0.065
Ask: 0.075
Change: 0.00 (0.00%)
Spread: 0.01 (15.385%)
Open: 0.07
High: 0.07
Low: 0.07
Prev. Close: 0.07
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings and Options Exercise

29 Mar 2010 16:44

RNS Number : 3688J
Adventis Group PLC
29 March 2010
 



29 March 2010

 

Adventis Group Plc ("Adventis", the "Group" or the "Company")

 

Issue of new shares and directors' dealings

 

Adventis Group plc (Adventis - ATG), the AIM-quoted full service multimedia marketing and advertising agency, announces the issue of 350,000 ordinary shares of 0.25p each in the Company ("New Ordinary Shares") to Charles Phillpot a director of the Company, pursuant to options granted on 20 October 2006 under the 2006 Long Term Incentive Plan that vested in full in October 2009.

 

Application has been made for the admission to trading on AIM of the New Ordinary Shares ("Admission") which will, upon Admission, rank pari passu with the Company's existing issued ordinary shares. Dealings are expected to commence on 30 March 2010.

 

Directors' dealings

 

The Company also announces that Charles Phillpot has today sold 150,000 ordinary 0.25p shares in the Company ("Shares") at a price of 18.5p per Share in order to raise the funds required to settle the tax and national insurance liabilities arising on the receipt of 350,000 New Ordinary Shares.

 

Following (i) the sale of these Shares and (ii) the issue of the New Ordinary shares, Charles Phillpot will hold 1,694,000 Shares representing approximately 3.57% of the total enlarged number of voting rights of the Company following Admission.

 

Aubrey Adams, also a director of the Company, has today acquired 250,000 Shares at a price of 18.5p per Share, and now holds 1,000,000 Shares, representing approximately 2.11% of the total enlarged number of voting rights of the Company following Admission.

 

Total Voting Rights

 

In accordance with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:

 

Following Admission of the 350,000 New Ordinary Shares on 30 March 2010 the Company's issued share capital will comprise 48,217,471 ordinary shares with a nominal value of 0.25p each, with voting rights. The Company will hold 728,953 Shares in Treasury.

 

Therefore the total number of Shares in the Company with voting rights will be 47,488,518.

 

The above figure of 47,488,518 Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

-ENDS-

 

 

Enquiries:

 

 

Adventis Group Plc

Charles Phillpot, CEO

020 7034 4750

Peter Linnell, Finance Director

020 7034 4795

Arbuthnot Securities Limited

Tom Griffiths

020 7012 2000

 

 

Notes to Editors:

 

Adventis Group is a marketing services and advertising agency. Its core areas of activity are healthcare, technology & telecoms, media and property. Subsidiary companies include: Adventis Health, Second2, bChannels, Adventis Media and Adventis Property.

For full details see www.adventis.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGUWCWUPUGAB
Date   Source Headline
1st Nov 20221:15 pmRNSCompletion of the Sale of Corallian to Shell
31st Oct 20229:08 amRNSPosting of Circular and Notice of Requisitioned GM
31st Oct 20227:00 amRNSPosting of Circular and Notice of Requisitioned GM
20th Oct 20227:00 amRNSRequisition of General Meeting
17th Oct 20221:00 pmRNSPurported Requisition of General Meeting
5th Oct 20223:30 pmRNSSPA for Sale of Corallian to Shell for £32 million
30th Sep 20227:00 amRNSUnaudited HY Results for 6 months ended 30/06/22
29th Sep 20227:02 amRNSPublication of PEDL183 CPR by RPS Energy
28th Sep 20227:00 amRNSConditional Acquisition of Simwell Resources
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
15th Sep 20227:00 amRNSAcquisition of North Sea Assets from Corallian
14th Sep 20227:00 amRNSAgreed Terms of Conditional Sale of Corallian
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
9th Sep 20227:00 amRNSResponse to Governmental Energy Plan
1st Sep 20227:00 amRNSUpdate on Corallian and acquisition of licences
14th Jul 20221:56 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSBoard Change
29th Jun 20224:31 pmRNSResults of Annual General Meeting
23rd Jun 20227:00 amRNSInvestor Presentation
21st Jun 20227:00 amRNSWest Newton Conceptual Development Plan
7th Jun 202211:53 amRNSNotice of AGM – correction of typographical error
1st Jun 202210:06 amRNSNotice of Annual General Meeting
27th May 20227:00 amRNSFull Year Results for the year ended 31 Dec 2021
26th May 20227:00 amRNSCompletion of Equity Exchange Agreement
24th May 20227:00 amRNSReabold North Sea – Presentation on New Licences
23rd May 20227:00 amRNSShareholder Approval Received for Equity Exchange
13th May 20227:00 amRNSAppointment of Chief Financial Officer
4th May 20227:00 amRNSOffer for Corallian and acquisition of licences
3rd May 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
17th Mar 202212:21 pmRNSPlanning Application Approval for Next Phase
25th Feb 20227:00 amRNSInvestor Presentation
25th Feb 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
24th Feb 20224:42 pmRNSSecond Price Monitoring Extn
24th Feb 20224:37 pmRNSPrice Monitoring Extension
17th Feb 202212:38 pmRNSAmendment of Existing Option Terms
25th Jan 20229:05 amRNSSecond Price Monitoring Extn
25th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn
20th Oct 202111:00 amRNSPrice Monitoring Extension
20th Oct 20217:00 amRNSVictory CPR and Corallian Strategic Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.